Project Grant R61DA062302
Award Date
9/30/24
Completion Date
8/31/26
Dollars Obligated
$799K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21250, USA
Similar Awards
The National Institutes of Health's National Institute on Drug Abuse awarded New York University School of Medicine a $1,446,310 Project Grant under the Drug Abuse and Addiction Research Programs to adapt an evidence-based posttraumatic stress disorder intervention for polysubstance use populations receiving treatment for opioid use disorder. Specifically, the award will support adapting an existing trauma-focused therapy, Skills Training in Affective and Interpersonal Regulation with...
This $2,729,018 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support the development and evaluation of a mobile health intervention for individuals with co-occurring opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) during community re-entry after residential OUD treatment. The project aims to use a ground-up approach to rigorously develop a mobile app with on-demand 24/7...
The National Institute of Mental Health (NIMH) awarded a Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Rutgers, The State University in the amount of $754,267 on September 3, 2024. The grant will fund a hybrid effectiveness-implementation trial to evaluate the use of massed prolonged exposure (M-PE) therapy for the concurrent treatment of posttraumatic stress disorder (PTSD) and substance use disorder (SUD) in a community SUD treatment program. The study aims...
This federal Project Grant award for $630,000.00 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant's objective is to develop and refine a brief, digitally-enhanced psychotherapeutic intervention called "IMPROVE: Managing Physical Reactions to Overwhelming Emotions" to reduce alcohol use among individuals receiving medications for opioid use disorder (MOUD). The project will be conducted in two phases....
This $440,092 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to develop and evaluate a novel digital therapeutic mobile application, OTX-601, for the treatment of post-traumatic stress disorder (PTSD) in adults. The project involves two phases: Phase I will focus on developing a usable app, determining the optimal dose, and assessing the feasibility, acceptability, and usability of OTX-601. It will also...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $913,261 to The Medical University of South Carolina (MUSC) to develop and evaluate a digital toolkit to address intimate partner violence (IPV) and co-occurring mental health conditions in opioid treatment programs (OTPs). The project, with an award period from September 2024 to August 2026, will first conduct stakeholder interviews to...
This $1,336,580 Project Grant, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will test the effectiveness, implementation, and cost of Cognitive Processing Therapy adapted for criminal justice settings (CPT-CJ) as an intervention to reduce post-incarceration drug use, mental health symptoms, and drug-related crime. The 5-year study will use a patient-randomized hybrid implementation-effectiveness design to compare CPT-CJ...
This Project Grant award from the National Institute on Drug Abuse (NIDA), funded under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to evaluate the efficacy of combining the drug guanfacine and the behavioral intervention mindfulness meditation as an adjunct to buprenorphine maintenance treatment for individuals with opioid use disorder (OUD). The $1,264,863 award, spanning September 2024 to August 2026, will be used to conduct a two-stage study. In the first...
This $2.9 million Defense Health Agency project grant funds research on suicide prevention among military personnel and veterans. The grant supports a multi-site randomized clinical trial through September 2026 to evaluate the efficacy of Written Exposure Therapy for Suicide Prevention compared to treatment as usual. Researchers at Boston University and partner institutions University of Colorado Denver and University of Texas Health Science Center San Antonio aim to reduce suicidal thoughts and...
This $1,278,253 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will establish the ARTEMIS (Advancing Addiction Research and Treatment through Engagement with Rural Marylanders Impacted by Polysubstance Use) Patient Engagement Resource Center at the University of Maryland, Baltimore (UMB). The primary objectives of this 5-year project are to: 1) Form a patient advisory committee focused on individuals with...